LincRNA-p21 Levels Relates to Survival and Post-Operative Radiotherapy Benefit in Rectal Cancer Patients

LincRNA-p21 Levels Relates to Survival and Post-Operative Radiotherapy Benefit in Rectal Cancer Patients

LincRNA-p21 is a long non-coding RNA involved in the p53 pathway and angiogenesis regulation that acts as prognostic marker in several tumors. In the present study, we aimed to analyze the clinical value of lincRNA-p21 in 177 resected stage I–III colorectal cancer (CRC) patients. Tumor and normal pa...

Full description

Bibliographic Details
Main Authors: Yan Li, Joan J. Castellano, Isabel Moreno, Francisco Martínez-Rodenas, Raquel Hernandez, Jordi Canals, Tania Diaz, Bing Han, Carmen Muñoz, Albert Biete, Mariano Monzo, Alfons Navarro
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Life
Subjects:
lincRNA-p21
colorectal cancer
radiochemotherapy
rectal cancer
long non-coding RNA
liquid biopsy
Online Access:https://www.mdpi.com/2075-1729/10/9/172

Internet

https://www.mdpi.com/2075-1729/10/9/172

Similar Items